Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rebecca Rawlinson
mTORC1 and DNA-PKcs as Novel Molecular Determinants of Sensitivity to Chk1 Inhibition
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
γH2AX and Chk1 Phosphorylation as Predictive Pharmacodynamic Biomarkers of Chk1 Inhibitor-Chemotherapy Combination Treatments
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Targeting Dna Double Strand Break Repair With Hyperthermia and Dna-PKCS Inhibition to Enhance the Effect of Radiation Treatment
Oncotarget
Oncology
DNA-PKcs Inhibition Sensitizes Cancer Cells to Carbon-Ion Irradiation via Telomere Capping Disruption
PLoS ONE
Multidisciplinary
Molecular Determinants of Site-Specific Inhibition of Human DNA Topoisomerase I by Fagaronine and Ethoxidine
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
DNA-PKcs, Allostery, and DNA Double-Strand Break Repair
DNA Repair Enzymes: Structure, Biophysics, and Mechanism
Tumour Growth Environment Modulates Chk1 Signalling Pathways and Chk1 Inhibitor Sensitivity
Scientific Reports
Multidisciplinary
Severe Combined Immunodeficiency Due to DNA-PKcs Deficiency
mTORC1 Inhibition Is Required for Sensitivity to PI3K P110 Inhibitors in PIK3CA-Mutant Breast Cancer
Science Translational Medicine
Medicine
Inhibition of Snail1-Dna-PKcs Protein-Protein Interface Sensitizes Cancer Cells and Inhibits Tumor Metastasis
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology